- Home
- AAL vs SNN Comparison
AAL vs SNN Comparison
Compare AAL & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AAL
- SNN
- Stock Information
- Founded
- AAL 1930
- SNN 1856
- Country
- AAL United States
- SNN United Kingdom
- Employees
- AAL N/A
- SNN N/A
- Industry
- AAL Air Freight/Delivery Services
- SNN Industrial Specialties
- Sector
- AAL Consumer Discretionary
- SNN Health Care
- Exchange
- AAL Nasdaq
- SNN Nasdaq
- Market Cap
- AAL 9.4B
- SNN 10.8B
- IPO Year
- AAL N/A
- SNN 1999
- Fundamental
- Price
- AAL $14.20
- SNN $25.03
- Analyst Decision
- AAL Buy
- SNN Strong Buy
- Analyst Count
- AAL 16
- SNN 1
- Target Price
- AAL $14.23
- SNN N/A
- AVG Volume (30 Days)
- AAL 25.9M
- SNN 1.1M
- Earning Date
- AAL 10-24-2024
- SNN 08-01-2024
- Dividend Yield
- AAL N/A
- SNN 2.99%
- EPS Growth
- AAL N/A
- SNN 39.77
- EPS
- AAL 0.42
- SNN 0.35
- Revenue
- AAL $53,613,000,000.00
- SNN $5,642,000,000.00
- Revenue This Year
- AAL $2.71
- SNN $6.97
- Revenue Next Year
- AAL $4.89
- SNN $5.46
- P/E Ratio
- AAL $33.89
- SNN $35.22
- Revenue Growth
- AAL 1.32
- SNN 5.48
- 52 Week Low
- AAL $9.07
- SNN $23.65
- 52 Week High
- AAL $16.15
- SNN $31.72
- Technical
- Relative Strength Index (RSI)
- AAL 61.16
- SNN 36.11
- Support Level
- AAL $13.84
- SNN $24.49
- Resistance Level
- AAL $14.44
- SNN $25.57
- Average True Range (ATR)
- AAL 0.42
- SNN 0.37
- MACD
- AAL -0.03
- SNN 0.15
- Stochastic Oscillator
- AAL 73.14
- SNN 60.51
About AAL American Airlines Group Inc.
American Airlines is the world's largest airline by aircraft, capacity, and scheduled revenue passenger miles. Its major US hubs are Charlotte, Chicago, Dallas/Fort Worth, Los Angeles, Miami, New York, Philadelphia, Phoenix, and Washington, D.C. It generates over 30% of US airline revenue connecting Latin America with destinations in the United States. After completing a major fleet renewal, the company has the youngest fleet of US legacy carriers.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 41% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.